BYNTOPHI Trademark

Trademark Overview

On Monday, February 4, 2019, a trademark application was filed for BYNTOPHI with the United States Patent and Trademark Office. The USPTO has given the BYNTOPHI trademark a serial number of 88288648. The federal status of this trademark filing is REGISTERED as of Tuesday, May 19, 2020. This trademark is owned by Generon (Shanghai) Corporation Ltd.. The BYNTOPHI trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for the treatment of stroke, spinal injury, neurological disorders, neurodegenerative diseases, and inflammation; pharmaceutical preparations used for stimulating white blood cell production
byntophi

General Information

Serial Number88288648
Word MarkBYNTOPHI
Filing DateMonday, February 4, 2019
Status700 - REGISTERED
Status DateTuesday, May 19, 2020
Registration Number6056258
Registration DateTuesday, May 19, 2020
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 3, 2020

Trademark Statements

Goods and Servicespharmaceutical preparations for the treatment of stroke, spinal injury, neurological disorders, neurodegenerative diseases, and inflammation; pharmaceutical preparations used for stimulating white blood cell production

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, February 26, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameEVIVE BIOTECHNOLOGY (SHANGHAI) LTD.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressShanghai 201207
CN
Party NameGeneron (Shanghai) Corporation Ltd.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressShanghai 201203
CN
Party NameGeneron (Shanghai) Corporation Ltd.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressShanghai 201203
CN
Party NameGeneron (Shanghai) Corporation Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressShanghai 201203
CN

Trademark Events

Event DateEvent Description
Monday, January 22, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 22, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, January 22, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, January 22, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, January 22, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, January 9, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, January 9, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 9, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, January 9, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, January 9, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, January 9, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, June 16, 2021AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Tuesday, May 19, 2020REGISTERED-PRINCIPAL REGISTER
Tuesday, March 3, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 3, 2020PUBLISHED FOR OPPOSITION
Wednesday, February 12, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, January 24, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 10, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, January 10, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 6, 2020ASSIGNED TO LIE
Friday, December 13, 2019TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, June 27, 2019NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, June 27, 2019LETTER OF SUSPENSION E-MAILED
Thursday, June 27, 2019SUSPENSION LETTER WRITTEN
Wednesday, April 17, 2019NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, April 17, 2019NON-FINAL ACTION E-MAILED
Wednesday, April 17, 2019NON-FINAL ACTION WRITTEN
Tuesday, April 16, 2019ASSIGNED TO EXAMINER
Tuesday, February 26, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 7, 2019NEW APPLICATION ENTERED

Related Keywords

byntophi preparations pharmaceutical stimulating used white blood production cell inflammation neurodegenerative